Niacinamide has had an extraordinary decade in skincare. From a relatively obscure B vitamin derivative used primarily in pharmaceutical preparations, it has become one of the most widely used cosmetic actives — appearing in moisturisers, serums, toners, and foundations across every price point. The clinical evidence for its efficacy is, by skincare standards, genuinely strong. The marketing around it is, by any standard, significantly exaggerated.
The niacinamide story is a useful case study in how a well-evidenced ingredient gets distorted by the concentration arms race.
What Niacinamide Does
Niacinamide (Niacinamide in INCI nomenclature, also known as nicotinamide or vitamin B3) has a well-documented range of effects on skin at appropriate concentrations:
Barrier function improvement — niacinamide stimulates the synthesis of ceramides, fatty acids, and cholesterol in the stratum corneum, improving skin barrier integrity and reducing transepidermal water loss (TEWL). This effect has been demonstrated in multiple independent clinical studies.
Sebum regulation — at concentrations of 2–4%, niacinamide has been shown to reduce sebum excretion rate in subjects with oily skin. A 2006 study published in the *International Journal of Dermatology* found that 2% niacinamide significantly reduced sebum production compared to vehicle control.
Hyperpigmentation — niacinamide inhibits the transfer of melanosomes from melanocytes to keratinocytes, reducing visible pigmentation. A 2002 study published in the *British Journal of Dermatology* found that 5% niacinamide significantly reduced hyperpigmentation compared to vehicle control over 8 weeks.
Anti-inflammatory effects — niacinamide has demonstrated anti-inflammatory activity in skin, reducing redness and improving the appearance of rosacea and acne. The mechanism involves inhibition of pro-inflammatory cytokines.
Fine lines and texture — at concentrations of 5%, niacinamide has been shown to improve the appearance of fine lines and skin texture in several clinical studies, likely through its effects on barrier function and collagen synthesis.
"The clinical evidence for niacinamide at 2–5% is among the strongest in the cosmetic ingredient category. The evidence for niacinamide at 10–20% is considerably thinner, and the evidence for concentrations above 5% providing proportionally greater benefit is largely absent."
The Concentration Arms Race
The skincare market has seen a dramatic escalation in niacinamide concentrations over the past five years. Products at 5% were the standard. Then 10% became common. Now 15%, 20%, and even higher concentrations are marketed as superior.
The clinical evidence does not support this escalation. The studies demonstrating niacinamide's efficacy were primarily conducted at 2–5%. Studies at higher concentrations are fewer, and the evidence for dose-dependent benefits above 5% is not established.
More significantly, there is evidence that niacinamide at high concentrations can cause adverse effects. A 2010 study published in the *Journal of Cosmetic Dermatology* found that niacinamide at concentrations above 5% increased the risk of skin flushing in some subjects — a reaction caused by the conversion of niacinamide to nicotinic acid (niacin), which causes vasodilation. This effect is more common with oral niacin but has been documented with high-concentration topical niacinamide.
The flushing reaction is not dangerous, but it is uncomfortable and can be mistaken for skin irritation or an allergic reaction. It is more likely to occur with high-concentration products and with products that have been improperly formulated (niacinamide can convert to nicotinic acid under certain pH and temperature conditions).
The Vitamin C Compatibility Myth
A persistent claim in skincare communities is that niacinamide and vitamin C (L-ascorbic acid) should not be used together because they form niacin (nicotinic acid), causing flushing. This claim has been widely repeated but is not supported by current evidence.
The concern originated from older research showing that niacinamide and ascorbic acid can form a 1:1 complex (nicotinic acid-ascorbic acid complex) under certain conditions. However, subsequent research has found that this reaction requires prolonged exposure at elevated temperatures — conditions that do not occur during normal product use or on skin.
A 2020 review in the *Journal of Cosmetic Dermatology* concluded that there is no clinically meaningful interaction between topical niacinamide and vitamin C under normal use conditions, and that the two ingredients can be used together safely.
The persistence of this myth illustrates how skincare misinformation spreads and how difficult it is to correct once established — even when the evidence clearly contradicts it.
What the INCI List Tells You
Niacinamide is a straightforward INCI name — there are no derivatives or alternative forms to decode. The position in the INCI list gives a rough indication of concentration. A product claiming "10% niacinamide" with Niacinamide listed after Glycerin (typically present at 3–10%) is making a concentration claim that may not be accurate.
The most reliable way to evaluate a niacinamide product is to look for:
Position in the INCI list — for a 5% product, niacinamide should appear in roughly the first third to half of the list, before most functional ingredients.
Concentration claim — brands that specify concentration (e.g., "5% Niacinamide") are making a verifiable claim. Brands that do not specify concentration may be using lower amounts than the marketing implies.
pH of the formulation — niacinamide is most stable and effective at pH 5–7. Formulations with very low pH (such as AHA exfoliants) may reduce niacinamide stability and could increase the risk of nicotinic acid conversion.
The Honest Assessment
Niacinamide at 2–5% is one of the best-evidenced, most versatile, and most cost-effective cosmetic actives available. It is genuinely useful for barrier repair, sebum control, hyperpigmentation, and mild anti-ageing effects. It is well-tolerated by most skin types, including sensitive skin.
Niacinamide at 10–20% is a marketing escalation without proportional clinical support. The evidence for superior efficacy at these concentrations is limited, and the risk of flushing reactions increases. A 5% niacinamide product from a reputable formulator is likely to be more effective than a 20% product that has been poorly formulated or stored.
The concentration arms race in niacinamide is a product of competitive marketing, not science. The number on the front of the bottle is not a reliable guide to efficacy.
